MARKETS
RELIANCETCSHDFCBANKINFYICICIBANKSBINITCLTBHARTIARTLAXISBANKMARUTISUNPHARMA

Innova Captab Ltd.

INNOVACAP · Pharmaceuticals & Drugs
₹996.50
▲ 16.30 (+1.66%)
Market dataas of 22 Oct 2026, 3:56 pm IST
52-week range · NSE26.4% below its high
Low ₹622.00High ₹1,353.50
60.2% above its low
Today’s range · NSE₹952.00 – ₹1,010.70
Low ₹952.00High ₹1,010.70
Opened at ₹978.00; 6.2% between low and high
P/E against its industry56% above the industry median
INNOVACAP40.5
Industry median25.9
Pharmaceuticals & Drugs · median of profitable companies in the industry
Market cap₹5,702 Cr
Current price₹996.50
Volume · NSE1.03 L
52w High / Low · NSE₹1,354 / ₹622
Stock P/E40.5
Industry P/E25.9
Book value₹190.61
Dividend yield0.20%
ROCE15.0%
ROE13.7%
Debt / Equity0.31
EPS (TTM)₹24.63
Face value₹10

Price

Daily candles · NSE

Price history isn’t available for this scrip.

What the numbers say

  • Good return on equity: 3-year ROE 15.0%.
  • Comfortable leverage: debt-to-equity of 0.31.
  • Sales compounded at 20.7% over 3 years.
  • Weak cash conversion (CFO/OP 0.53).
  • Trades above its industry P/E (40.5 vs 25.9).

Generated automatically from reported financials. These are observations, not a recommendation to buy or sell.

  • Board Meeting

    Audited Results

Company announcements as filed with the exchanges. Reproduced for information — not a view or a recommendation.

Profit & Loss · ₹ croreFY26FY25FY24FY23FY22
Net Sales1,6301,2441,081926801
Other income19121293
Total Income1,6491,2561,094936803
Expenditure1,3981,058927813705
Operating Profit25019816712399
Interest17221206
Depreciation452516118
Profit before tax1881711309286
Tax4743352422
Net Profit141128946864
EPS (₹)24.6322.4118.6614.16—
Net margin %8.610.38.77.38.0

Consolidated figures, as filed with the exchanges. Newest year first. EPS for FY22, FY21 is not shown: the value supplied does not agree with the number of shares the company reported for that year, and we would rather show nothing than a figure we cannot reconcile.

Balance Sheet · ₹ croreFY26FY25FY24FY23FY22
Equity capital5757574812
Reserves1,034902774229197
Net worth1,091959831277209
Total sources1,3191,2141,051467295
Net block842830358183183
Capital work in progress1623341220
Investments97132210129
Inventory283208144117128
Debtors437332288265213
Cash & bank46887192
Book value (₹)190.61167.66145.2057.611738.38

Consolidated figures, as filed with the exchanges. Newest year first. Innova Captab Ltd. had roughly 40× as many shares from FY23 onwards, after a bonus issue or a share split. Book value per share is shown exactly as reported, so FY22 and earlier is struck on the smaller share count and is not comparable with the years after it. The totals above are unaffected.

Cash Flow · ₹ croreFY26FY25FY24FY23FY22
From operations117641466759
From investing-107-152-499-91-188
From financing-229236127125
Net change in cash-12483-5
Free cash flow9-88-353-24-129
Closing cash3161240

Consolidated figures, as filed with the exchanges. Newest year first.

RatiosFY26FY25FY24FY23FY22
ROCE %15.014.619.124.330.6
ROE %13.714.317.028.036.2
PAT margin %8.510.18.77.27.9
EBIT margin %12.413.713.911.911.3
Debt / equity0.310.350.290.850.95
Current ratio1.831.912.071.591.27
Interest cover12.1472.117.045.6016.09
Sales growth %31.115.016.715.794.9
Dividend per share (₹)2.000.000.000.000.00
Payout %8.10.00.00.00.0

Consolidated figures, as filed with the exchanges. Newest year first.

Frequently asked

Innova Captab Ltd. (INNOVACAP) last traded at ₹996.50 on the NSE, up +1.66% on the session. Prices on this page are indicative and for information only.

Innova Captab Ltd. has traded between ₹622.00 and ₹1,353.50 over the last 52 weeks on the NSE.

Innova Captab Ltd. has a market capitalisation of about ₹5,702 crore.

Innova Captab Ltd. trades at a P/E of 40.5, against an industry P/E of 25.9.

Open a trading and Demat account with Labdhi — it is fully digital with paperless KYC — then place a buy order for INNOVACAP from the Labdhi app or web platform.

Yes. You can invest in equities in a staggered manner through Labdhi. Speak to your Labdhi adviser about a plan suited to your goals and risk profile.

Who is actually trading it

Delivery against churn, the deals big enough to be reported, what the insiders did, and the benchmarks that hold Innova Captab Ltd..

Loading trading activity…

Exchange filings and end-of-day data, not a live feed. Bulk, block and insider records are published by the exchanges when a threshold is crossed, so they show reportable activity only. For information, not a recommendation to deal, and not a view on any person named above.

Disclosures. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Prices and data on this page are indicative and for information only. Nothing here is investment advice or a recommendation to buy or sell any security. Investors should consider their own objectives, financial situation and risk profile, and may wish to seek independent advice, before investing.

Figures are as reported by the company; consolidated where available. Errors and omissions excepted.

L. F. C. Securities Pvt. Ltd. · Member BSE, NSE, MCX · SEBI Stock Broker INZ000170736 · CDSL IN-DP-281-2016 · AMFI ARN-78991 · Investment Adviser (Non-Individual) INA000011617 · Compliance Officer: Mr. Santosh Patil · santoshp@labdhi.in · 022-35006933 · Investor Grievances: investorgreve@labdhi.in